LYEL logo

Lyell Immunopharma (LYEL)

Profile

Full Name

Lyell Immunopharma, Inc.

Ticker Symbol

LYEL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 17, 2021

Indexes

Not included

Website

http://www.lyell.com

Employees

300

Key Details

Price

$0.42(+5.40%)

Market cap

$124.47M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$61.00K(-53.08% YoY)

Annual EPS

-$1.31(-40.86% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.42
    LYEL price is $0.42

    30-Day Relative Volume

    1.30
    LYEL 30-day relative volume is 1.30

    Price Performance

    Price Most recent change

    +5.4%
    LYEL price was up +5.4% on May 12, 2025

    Price YTD change

    -34.12%
    LYEL price is down -34.12% since January 1st

    Price 1-year change

    -82.86%
    LYEL price is down -82.86% year-on-year

    Price 3-year change

    -89.74%
    LYEL price is down -89.74% over the past 3 years

    Price Range

    Price All-time high

    $19.84
    LYEL price is currently -97.88% below its historical high of $19.84

    Price 3-year low

    $0.39
    LYEL price is currently +8.10% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $124.47M
    LYEL market capitalization is $124.47 million

    Market cap 3-year change

    -87.7%
    LYEL market capitalization is down -87.7% over the past 3 years

    Market cap All-time high

    $4.30B
    LYEL market capitalization is currently -97.10% below its historical high of $4.30 billion

    Market cap sector rank

    49.84%
    LYEL market capitalization is higher than 49.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.8%
    LYEL shares outstanding is up +15.8% year-on-year

    Shares Outstanding 3-Year Change

    +19.95%
    LYEL shares outstanding is up +19.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.26
    LYEL beta is 1.26

    200-day SMA

    $0.90
    LYEL price is currently -53.00% below its 200-day simple moving average

    50-day SMA

    $0.51
    LYEL price is currently -17.98% below its 50-day simple moving average

    RSI

    42.49
    LYEL 14-day relative strength index is 42.49

    Volume

    1.30
    LYEL 30-day relative volume is 1.30

    ATR

    $0.05
    LYEL average true range is $0.05

    10-day Historical Volatility

    80.92%
    LYEL 10-day historical volatility is 80.92%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $61.00K
    LYEL annual revenue is $61.00 thousand

    Revenue Analysts estimate

    $32.50K
    LYEL annual revenue is currently +87.69% higher than the consensus analysts' forecast

    Revenue 1-year change

    -53.08%
    LYEL annual revenue is down -53.08% year-on-year

    Revenue Sector rank

    4.41%
    LYEL annual revenue is higher than 4.41% of companies in Healthcare sector

    EPS

    EPS

    -$1.31
    LYEL annual earnings per share is -$1.31

    EPS Analysts estimate

    -$0.45
    LYEL annual earnings per share is currently +191.11% higher than the consensus analysts' forecast

    EPS 1-year change

    -40.86%
    LYEL annual earnings per share is down -40.86% year-on-year

    EPS Sector rank

    48.8%
    LYEL annual earnings per share is higher than 48.8% of companies in Healthcare sector

    Profit

    Gross profit

    -
    LYEL annual gross profit value is unknown

    Gross margin

    -
    LYEL annual gross profit margin value is unknown

    Operating profit

    -$220.27M
    LYEL annual operating income is -$220.27 million

    Operating margin

    -361.10K%
    LYEL annual operating profit margin is -361.10 thousand%

    Net income

    -$342.99M
    LYEL annual net profit is -$342.99 million

    Net margin

    -562.29K%
    LYEL annual net profit margin is -562.29 thousand%

    Expenses

    Total expenses

    $220.34M
    LYEL annual total expenses is $220.34 million

    Operating expenses

    $220.34M
    LYEL annual total operating expenses is $220.34 million

    Cost of goods sold

    -
    LYEL annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $52.04M
    LYEL annual SGA is $52.04 million

    Depreciation and amortization

    $19.63M
    LYEL annual depreciation & amortization is $19.63 million

    Interest expense

    -
    LYEL annual interest expense value is unknown

    Income tax

    -
    LYEL annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$220.27M
    LYEL annual earnings before interest & taxes is -$220.27 million

    EBITDA

    -$200.64M
    LYEL annual EBITDA is -$200.64 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $490.86M
    LYEL annual total assets is $490.86 million

    Non current assets

    $111.27M
    LYEL annual long term assets is $111.27 million

    Current assets

    $379.59M
    LYEL annual total current assets is $379.59 million

    Cash and cash equivalents

    $105.60M
    LYEL annual cash & cash equivalents is $105.60 million

    Accounts receivable

    -
    LYEL annual accounts receivable value is unknown

    Inventory

    -
    LYEL annual inventory value is unknown

    Liabilities

    Total liabilities

    $108.03M
    LYEL annual total liabilities is $108.03 million

    Long term liabilities

    $54.25M
    LYEL annual total long term liabilities is $54.25 million

    Current liabilities

    $53.79M
    LYEL annual total current liabilities is $53.79 million

    Accounts payable

    $5.37M
    LYEL annual accounts payable is $5.37 million

    Debt

    Total debt

    $58.97M
    LYEL annual total debt is $58.97 million

    Total debt 1-year change

    -6.65%
    LYEL annual total debt is down -6.65% year-on-year

    Long term debt

    $50.99M
    LYEL annual long term debt is $50.99 million

    Short term debt

    $7.97M
    LYEL annual short term debt is $7.97 million

    Equity & Capital

    Shareholders equity

    $382.82M
    LYEL annual stockholders equity is $382.82 million

    Book value

    $382.82M
    LYEL annual book value is $382.82 million

    Retained earnings

    -$1.35B
    LYEL annual retained earnings is -$1.35 billion

    Working capital

    $325.81M
    LYEL annual working capital is $325.81 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$162.39M
    LYEL annual cash flow from operations is -$162.39 million

    Cash from operations 1-year change

    +0.79%
    LYEL annual cash flow from operations is up +0.79% year-on-year

    Cash from investing

    $122.42M
    LYEL annual cash flow from investing activities is $122.42 million

    Cash from investing 1-year change

    -33.48%
    LYEL annual cash flow from investing activities is down -33.48% year-on-year

    Cash from financing

    $1.33M
    LYEL annual cash flow from financing activities is $1.33 million

    Cash from financing 1-year change

    -23.92%
    LYEL annual cash flow from financing activities is down -23.92% year-on-year

    CAPEX

    CAPEX

    $464.00K
    LYEL annual capital expenditures is $464.00 thousand

    CAPEX 1-year change

    -82.73%
    LYEL annual capital expenditures is down -82.73% year-on-year

    Free Cash Flow

    Free cash flow

    -$162.86M
    LYEL annual free cash flow is -$162.86 million

    Free cash flow 1-year change

    +2.12%
    LYEL annual free cash flow is up +2.12% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    LYEL annual gross profit margin value is unknown

    Operating margin

    -361.10K%
    LYEL annual operating profit margin is -361.10 thousand%

    Net margin

    -562.29K%
    LYEL annual net profit margin is -562.29 thousand%

    ROA & ROE

    ROA

    -55.28%
    LYEL annual return on assets is -55.28%

    ROE

    -66.10%
    LYEL annual return on equity is -66.10%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LYEL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LYEL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.33
    LYEL price to book ratio is 0.33

    PB ratio Sector rank

    24.47%
    LYEL price to book ratio is higher than 24.47% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2040.47
    LYEL price to sales ratio is 2040.47

    PS ratio Sector rank

    98.96%
    LYEL price to sales ratio is higher than 98.96% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $77.84M
    LYEL enterprise value is $77.84 million

    Enterprise value Sector rank

    45.3%
    LYEL enterprise value is higher than 45.3% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.39
    LYEL EV/EBITDA is -0.39

    EV/EBITDA Sector rank

    55.48%
    LYEL EV/EBITDA is higher than 55.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.06
    LYEL annual current ratio is 7.06

    Quick ratio

    -
    LYEL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    LYEL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    LYEL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    LYEL piotroski f-score value is unknown

    Altman Z-Score

    -3.83
    LYEL altman z-score is -3.83

    Analyst ratings

    Recent major analysts updates

    Apr 16, 25 HC Wainwright & Co.
    Neutral
    Mar 13, 25 HC Wainwright & Co.
    Neutral
    Nov 12, 24 HC Wainwright & Co.
    Neutral
    Oct 30, 24 B of A Securities
    Underperform
    Oct 28, 24 HC Wainwright & Co.
    Neutral
    Aug 19, 24 HC Wainwright & Co.
    Neutral
    Jun 27, 24 HC Wainwright & Co.
    Neutral
    Jun 27, 24 B of A Securities
    Buy
    May 7, 24 HC Wainwright & Co.
    Buy
    Feb 29, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LYEL included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Lyell Immunopharma?
    • Does Lyell Immunopharma pay dividends?
    • What sector is Lyell Immunopharma in?
    • What industry is Lyell Immunopharma in?
    • What country is Lyell Immunopharma based in?
    • When did Lyell Immunopharma go public?
    • Is Lyell Immunopharma in the S&P 500?
    • Is Lyell Immunopharma in the NASDAQ 100?
    • Is Lyell Immunopharma in the Dow Jones?
    • When was Lyell Immunopharma's last earnings report?
    • When does Lyell Immunopharma report earnings?
    • Should I buy Lyell Immunopharma stock now?

    What is the ticker symbol for Lyell Immunopharma?

    The ticker symbol for Lyell Immunopharma is NASDAQ:LYEL

    Does Lyell Immunopharma pay dividends?

    No, Lyell Immunopharma does not pay dividends

    What sector is Lyell Immunopharma in?

    Lyell Immunopharma is in the Healthcare sector

    What industry is Lyell Immunopharma in?

    Lyell Immunopharma is in the Biotechnology industry

    What country is Lyell Immunopharma based in?

    Lyell Immunopharma is headquartered in United States

    When did Lyell Immunopharma go public?

    Lyell Immunopharma's initial public offering (IPO) was on June 17, 2021

    Is Lyell Immunopharma in the S&P 500?

    No, Lyell Immunopharma is not included in the S&P 500 index

    Is Lyell Immunopharma in the NASDAQ 100?

    No, Lyell Immunopharma is not included in the NASDAQ 100 index

    Is Lyell Immunopharma in the Dow Jones?

    No, Lyell Immunopharma is not included in the Dow Jones index

    When was Lyell Immunopharma's last earnings report?

    Lyell Immunopharma's most recent earnings report was on Mar 11, 2025

    When does Lyell Immunopharma report earnings?

    The next expected earnings date for Lyell Immunopharma is May 13, 2025

    Should I buy Lyell Immunopharma stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page